Clinical Trials on Periampullary Carcinoma Resectable in France

Total 2834 results

Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France; Groupement... and other collaborators

Recruiting

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis (SEPT9-CROSS)

Hepatocellular Carcinoma | Cirrhosis

France
Puma Biotechnology, Inc.

Completed

Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors

Neoplasms | Malignant Carcinoma

United States, France
Centre Oscar Lambret
National Cancer Institute, France

Completed

Stereotaxic Irradiation of Hepatocellular Carcinoma (CKNO-HEP)

Hepatocellular Carcinoma

France
National Cancer Institute (NCI)

Recruiting

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Anal Canal Cloacogenic Carcinoma | Metastatic Anal Squamous Cell Carcinoma | Recurrent Anal Squamous Cell Carcinoma | Stage III Anal Cancer AJCC v8 | Stage IV Anal Cancer AJCC v8 | Unresectable Anal Squamous Cell Carcinoma | Anal Basaloid Squamous Cell Carcinoma

United States
Centre Georges Francois Leclerc

Completed

A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC (IMKRUN 2)

Carcinoma, Non-Small-Cell Lung

France
Assistance Publique - Hôpitaux de Paris

Terminated

Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma (ITOV04)

Ovarian Cancer | Relapses

France
National Cancer Institute (NCI)

Active, not recruiting

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

Metastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell Carcinoma | TFE3-Rearranged Renal Cell Carcinoma

United States, Puerto Rico
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Carcinoma

France
Centre Hospitalier Universitaire Dijon
National Cancer Institute, France

Recruiting

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary (FOLFIRINEC)

Neuroendocrine Carcinoma

France
Assistance Publique - Hôpitaux de Paris

Terminated

Major RF Ablations of Hepatomas Under MR Thermometry Monitoring (ARMTICH)

Hepatocellular Cancer

France
University Hospital, Toulouse

Recruiting

Bio Clinical Collection of Urothelial Carcinoma (MicroBlad)

Bladder Cancer | Urothelial Carcinoma

France
UNICANCER

Terminated

Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss (COPAN-ORL06)

Carcinoma, Squamous Cell of Head and Neck

France
National Cancer Institute (NCI)

Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Clinical Stage... and other conditions

United States
Centre Hospitalier Universitaire de Saint Etienne

Terminated

Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection. (BLOC-TAP)

Liver Cancer, Adult

France
Federation Francophone de Cancerologie Digestive

Completed

Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II (IDASPHERE II)

Liver Cancer

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

Laryngeal Preservation in Pyriform Sinus Carcinoma

Squamous Cell Carcinoma

France
R-Pharm

Completed

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

Metastatic Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast Cancer

Czech Republic, Italy, Poland, Spain, Austria, France, Greece
Centre Henri Becquerel

Not yet recruiting

Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer (OPTINECK)

Squamous Cell Carcinoma of Head and Neck

France
National Cancer Institute (NCI)
Canadian Cancer Trials Group

Active, not recruiting

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Unresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell Carcinoma

United States, Canada
European Lung Cancer Working Party

Completed

Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

Small Cell Lung Carcinoma, Extensive Disease

Belgium, France, Greece, Spain
University Hospital, Brest

Completed

Itch and Pain Characteristics in Skin Carcinomas (PRURITCC)

Skin Cancer | Pruritus | Skin Carcinoma

France
Institut Curie

Completed

Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma (FibroRect)

Rectum Adenocarcinoma

France
Rennes University Hospital

Terminated

Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma (CATCH)

Hepatocellular Carcinoma

France
EverImmune

Recruiting

A Study of Oncobax®-AK in Patients With Advanced Solid Tumors

Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung

France, Belgium
Centre Leon Berard
Centre de Recherche en Cancérologie de Lyon (CRCL)

Recruiting

Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma (GYNECO-IMM&CO)

Breast Carcinoma | Ovarian Carcinoma

France
Gilead Sciences
Everest Medicines

Active, not recruiting

Study of Sacituzumab Govitecan-hziy (IMMU-132) Versus Treatment of Physician's Choice in Participants With Metastatic or Locally Advanced Unresectable Urothelial Cancer (TROPiCS-04)

Locally Advanced or Metastatic Unresectable Urothelial Cancer

United States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
Centre Hospitalier Universitaire Dijon

Completed

Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients (CIRCE)

Cirrhosis With Hepatocellular Carcinoma | Cirrhosis Without Hepatocellular Carcinoma

France
University Hospital, Rouen

Completed

Influence of Probiotics Administration Before Liver Resection in Liver Disease (LIPROCES)

Liver Cirrhosis | Hepatocellular Carcinoma | Liver Fibrosis | Permeability; Increased

France
St. Joseph Hospital of Orange

Completed

Single Fraction Intraoperative Radiotherapy

Stage 0 Breast Carcinoma | Stage I Breast Carcinoma | Stage II Breast Carcinoma | Invasive Ductal and Invasive Lobular Breast Carcinoma

United States
Amgen

Completed

AMG 172 First in Human Study in Patients With Kidney Cancer

Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Clear Cell Renal Carcinoma | Renal Cell Adenocarcinoma

France, United States, Germany
Centre Hospitalier Universitaire de Besancon
GERCOR - Multidisciplinary Oncology Cooperative Group; PRODIGE

Recruiting

Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma (TERTIO)

Hepatocellular Carcinoma

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux (2007-01)

HNSCC

France
Incyte Corporation

Completed

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Metastatic Melanoma | Unresectable Melanoma | Metastatic Urothelial Cancer | Metastatic Non-small Cell Lung Cancer | Locally Advanced Renal Cell Carcinoma | Locally Advanced Urothelial Cancer | Metastatic Clear-Cell Renal Cell Carcinoma

France, Spain, United States, Italy, Austria, Romania, Poland, Hungary
University Hospital, Lille

Completed

MRI Perfusion on T1 and T2 Brain Lesion(s) (METAPERF)

Lung Carcinoma Metastatic to the Brain

France
Centre Antoine Lacassagne

Recruiting

18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma (FDG-IMMUN)

Non-Small Cell Bronchopulmonary Carcinoma or Melanoma

France
Centre Hospitalier Régional Universitaire Montpellier

Completed

Pulmonary Function After Arterial Sleeve Lobectomy

Lung Cancer, Nonsmall Cell

France
Eli Lilly and Company

Completed

A Study for Participants With Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

Austria, France, Italy, Poland
BeiGene

Active, not recruiting

Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer

Nonsmall Cell Lung Cancer, Stage IV | Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)

United States, China, Korea, Republic of, France, Spain, Australia, Austria
Nantes University Hospital
Institut National de la Santé Et de la Recherche Médicale, France; Gilead Sciences

Completed

ImmunoTEP for Patients With Medullary Thyroid Carcinoma. (iTEP-CMT)

Medullary Thyroid Carcinoma

France
University Hospital, Clermont-Ferrand

Completed

Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers (MYOCACH)

Head and Neck Cancer | Cachexia | Squamous Cell Carcinoma

France
University Hospital, Tours
Inserm U1069 - Team Nutrition, Growth and Cancer

Completed

Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss (METERMUS-IMC)

Weight Loss | Endometrial Carcinoma | Ovarian Carcinoma

France
Intergroupe Francophone de Cancerologie Thoracique
Sanofi; AstraZeneca

Completed

Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV

Carcinoma, Non-Small-Cell Lung

France
Centre Hospitalier Universitaire de Besancon
Novartis; National Cancer Institute, France

Recruiting

Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma (SPARTANA)

Squamous Cell Anal Carcinoma | Metastatic Squamous Cell Carcinoma

France
AbbVie

Recruiting

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) (LIVIGNO-2)

Hepatocellular Carcinoma

United States, Taiwan, Spain, France
Centre Georges Francois Leclerc

Recruiting

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT) (IMMUNOs-SBRT)

Metastatic Renal Cell Carcinoma | Metastatic Non Small Cell Lung Cancer | Metastatic Head and Neck Cancer | Metastatic Bladder Cancer

France
Assistance Publique - Hôpitaux de Paris

Completed

Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging (REMISCAN)

Carcinoma, Renal Cell

France
Centre Hospitalier Universitaire de Nīmes

Completed

Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx (RoboCurage ORL)

Carcinoma, Squamous Cell

France
IHU Strasbourg

Recruiting

Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients (STARHE)

Hepatocellular Carcinoma | Chronic Liver Disease

France
University Hospital, Angers

Unknown

SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 (CBPC)

Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris

Terminated

Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector (SECCI)

Liver Cirrhosis | Carcinoma, Hepatocellular | Liver Neoplasms

France

Clinical Trials on Periampullary Carcinoma Resectable in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations